Pharmacotherapy of PTSD

Dan J. Stein; Jonathan C. Ipser

doi:10.1002/9781119998471.ch4

Pharmacotherapy of PTSD

Dan J. Stein, Jonathan C. Ipser

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

2 Scopus citations

Original language	English
Title of host publication	Post-Traumatic Stress Disorder
Publisher	John Wiley and Sons
Pages	149-162
Number of pages	14
ISBN (Print)	9780470688977
DOIs	https://doi.org/10.1002/9781119998471.ch4
State	Published - 15 Jul 2011

Keywords

Advances, in pharmacotherapy - post-traumatic stress disorder (PTSD)
Epidemiological data, exposure to traumatic stress - a minority, developing PTSD
Evidence base for pharmacotherapy of PTSD - recommendation, SSRIs as first-line pharmacotherapy for PTSD
Optimal SSRI (or SNRI) - for pharmacotherapy of PTSD
PTSD prophylaxis, interest - pharmacotherapy effectiveness in PTSD prophylaxis
Pharmacotherapy and psychotherapy - pharmacotherapy versus psychotherapy, treatment of PTSD
Pharmacotherapy of PTSD
Rigorous empirical trials, risks and benefits - pharmacotherapeutic intervention examined
SSRIs advancing, good safety profile - potential, to moving the risk
Selected SSRI trials in PTSD

Access to Document

10.1002/9781119998471.ch4

Cite this

@inbook{87d623ba186244bca2908d126228b4d5,

title = "Pharmacotherapy of PTSD",

keywords = "Advances, in pharmacotherapy - post-traumatic stress disorder (PTSD), Epidemiological data, exposure to traumatic stress - a minority, developing PTSD, Evidence base for pharmacotherapy of PTSD - recommendation, SSRIs as first-line pharmacotherapy for PTSD, Optimal SSRI (or SNRI) - for pharmacotherapy of PTSD, PTSD prophylaxis, interest - pharmacotherapy effectiveness in PTSD prophylaxis, Pharmacotherapy and psychotherapy - pharmacotherapy versus psychotherapy, treatment of PTSD, Pharmacotherapy of PTSD, Rigorous empirical trials, risks and benefits - pharmacotherapeutic intervention examined, SSRIs advancing, good safety profile - potential, to moving the risk, Selected SSRI trials in PTSD",

author = "Stein, {Dan J.} and Ipser, {Jonathan C.}",

year = "2011",

month = jul,

day = "15",

doi = "10.1002/9781119998471.ch4",

language = "English",

isbn = "9780470688977",

pages = "149--162",

booktitle = "Post-Traumatic Stress Disorder",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Pharmacotherapy of PTSD

AU - Stein, Dan J.

AU - Ipser, Jonathan C.

PY - 2011/7/15

Y1 - 2011/7/15

KW - Advances, in pharmacotherapy - post-traumatic stress disorder (PTSD)

KW - Epidemiological data, exposure to traumatic stress - a minority, developing PTSD

KW - Evidence base for pharmacotherapy of PTSD - recommendation, SSRIs as first-line pharmacotherapy for PTSD

KW - Optimal SSRI (or SNRI) - for pharmacotherapy of PTSD

KW - PTSD prophylaxis, interest - pharmacotherapy effectiveness in PTSD prophylaxis

KW - Pharmacotherapy and psychotherapy - pharmacotherapy versus psychotherapy, treatment of PTSD

KW - Pharmacotherapy of PTSD

KW - Rigorous empirical trials, risks and benefits - pharmacotherapeutic intervention examined

KW - SSRIs advancing, good safety profile - potential, to moving the risk

KW - Selected SSRI trials in PTSD

UR - http://www.scopus.com/inward/record.url?scp=84886574744&partnerID=8YFLogxK

U2 - 10.1002/9781119998471.ch4

DO - 10.1002/9781119998471.ch4

M3 - Chapter

AN - SCOPUS:84886574744

SN - 9780470688977

SP - 149

EP - 162

BT - Post-Traumatic Stress Disorder

PB - John Wiley and Sons

ER -